Latest Cancer News

Read the latest cancer news from the National Cancer Institute. The UNM Comprehensive Cancer Center is one of only 49 NCI-designated comprehensive cancer centers bringing leading, national cancer care to New Mexico.

Osimertinib Improves Survival in Advanced Lung Cancer with EGFR Mutations

Osimertinib (Tagrisso) improves survival in people with non-small cell lung cancer with EGFR mutations, updated clinical trial results show. People treated with osimertinib lived longer than those treated with earlier-generation EGFR-targeted drugs.

Surgery for Recurrent Ovarian Cancer Does Not Improve Survival

Secondary surgery for women with recurrent ovarian cancer does not improve how long those women live, findings from a large trial show. The results call into question the current standard of practice for these patients.

Overcoming a Cancer Nemesis? KRAS Inhibitor Shows Promise in Early Trial

An experimental drug, AMG 510, that targets mutated forms of the KRAS protein completely shrank tumors in cancer mouse models and data from a small clinical trial show that it appears to be active against different cancer types with a KRAS mutation.

As Use of Genomic Data Expands in Cancer Care, Patients Share Their Stories

At a recent NCI-sponsored scientific workshop, patients with cancer, researchers, and patient advocates exchanged ideas about personal genomic data, issues related to privacy, and data sharing.

Gilteritinib Improves Survival in AML with FLT3 Mutations

People with relapsed or refractory acute myeloid leukemia (AML) with FLT3 gene mutations treated with gilteritinib had improved survival, higher rates of remission, and fewer side effects than those treated with chemotherapy, a recent trial found.

Children with Acute Lymphoblastic Leukemia Can Skip Radiation to the Brain

Only 1.5% of children with acute lymphoblastic leukemia who skipped radiation had a recurrence in the central nervous system, according to a recent trial. The therapy, which is intended to prevent such a recurrence, can have devastating side effects.

Some Brain Cells May Help to Fuel Cancer Metastasis

Brain cells called astrocytes can activate PPAR-gamma, a growth protein in cancer cells that helps them gain a foothold in the brain, a new study shows. The findings suggest that drugs that block PPAR-gamma activity may help treat brain metastases.

Epigenetic Changes Pinpointed as the Cause of Some GISTs

Scientists may have pinpointed the cause of some gastrointestinal stromal tumors (GISTs), a rare cancer, according to a new NCI-funded study. However, the culprit isn’t a harmful genetic mutation, but another type of genetic change, what are called epigenetic alterations.

Prescribing Exercise as Cancer Treatment: A Conversation with Dr. Kathryn Schmitz

Updated guidelines on exercise in those living with cancer and cancer survivors were recently released. In this conversation, Dr. Kathryn Schmitz discusses what these new guidelines mean for doctors, patients, and survivors.

Home Is Where the Heart Is

Dr. Ned Sharpless discusses his return as NCI director after serving as acting commissioner of the Food and Drug Administration for 7 months.